We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Double-bridged Peptide Tailored to Bind Tightly to Disease Targets of Interest

News   May 02, 2018 | Original story from Ecole Polytechnique Fédérale de Lausanne

 
Double-bridged Peptide Tailored to Bind Tightly to Disease Targets of Interest

A model of a double-bridged peptide (the peptide in light blue, the two bridges in yellow). The background of the figures shows many examples of skeletons (also named "scaffolds" or "backbones") of double-bridged peptides. Credit: C. Heinis/EPFL

 
 
 

RELATED ARTICLES

Antibody Injection Temporarily Stops Peanut Allergy

News

A new study has provided early evidence that an antibody is a safe, effective and rapid food allergy treatment.

READ MORE

A Change in Cell Logistics Helps Cancer Become Resistant

News

Researchers have discovered that breast cancers which had become resistant to hormone therapy have a molecular "advantage" that helps the cells successfully evade hormone therapies.

READ MORE

Spread of Breast Cancer Stopped by Blocking Enzyme

News

By blocking the activity of a single enzyme it is possible to prevent a common type of breast cancer from spreading to distant organs.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE